These outcomes, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the strategy of focusing on ACKR3 as a novel way to modulate the opioid system, which could open new therapeutic avenues for opioid-relevant Problems.A investigate review revealed in Anesthesiology